Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Callos Andrew
Over the trailing 90 days, Callos Andrew (Other Officer at CYTOKINETICS INC) traded $5.9M of stock (net selling $2.9M) in CYTK, per 12 SEC Form 4 transactions.
- Role
- Other Officer
- Companies
- CYTK
- Window
- Trailing 90 days · 12 transactions · CIK 1852129
- Net activity
- −$2.9M ($1.5M bought · $4.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 12 | $1.5M | $4.4M | −$2.9M |
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-30 | CYTK | Buy | 14.0K | $326K | Exercise or conversion of derivative security |
| 2026-07-30 | CYTK | Sell | 14.0K | $1.1M | Open market or private sale |
| 2026-07-30 | CYTK | Sell | 14.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-01 | CYTK | Sell | 15.0K | $1.3M | Open market or private sale |
| 2026-07-01 | CYTK | Buy | 15.0K | $349K | Exercise or conversion of derivative security |
| 2026-07-01 | CYTK | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-01 | CYTK | Buy | 15.0K | $349K | Exercise or conversion of derivative security |
| 2026-06-01 | CYTK | Sell | 15.0K | $1.1M | Open market or private sale |
| 2026-06-01 | CYTK | Sell | 15.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-05 | CYTK | Sell | 11.3K | $875K | Open market or private sale |
| 2026-05-05 | CYTK | Buy | 11.3K | $443K | Exercise or conversion of derivative security |
| 2026-05-05 | CYTK | Sell | 11.3K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Callos's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.